Abstract:Background & Aims Natural killer (NK) cells are key players in tumor immunosurveillance and metabolic adaption manipulates their fate and functional state. The nicotinamide adenine dinucleotide (NAD+) has emerged as a vital factor to link cellular metabolism and signaling transduction. Here, we identified NAD+ metabolism as a central hub to determine the homeostasis and function of NK cells. Approach & Results NAD+ level was elevated in activated NK cells. NAD+ supplementation not only enhanced cytokine production and cytotoxicity, but also improved the proliferation and viability of NK cells. Intriguingly, the salvage pathway was involved in maintaining NAD+ homeostasis in activated NK cells. Genetic ablation or pharmacological blockade of nicotinamide phosphoribosyltransferase (NAMPT), the rate‐limiting enzyme in the NAD+ salvage pathway, markedly destroyed the viability and function of NK cells. Mechanistically, NAD+ salvage dictated the mitochondrial homeostasis and oxidative phosphorylation activity to support the optimal function of NK cells. However, in human hepatocellular carcinoma (HCC) tissues, NAMPT expression and NAD+ level were significantly downregulated in tumor‐infiltrating NK cells (TINKs), which negatively correlated with patient survival. And, lactate accumulation in tumor microenvironment was at least partially responsible for the transcriptional repression of NAMPT in NK cells. Further, deficiency of Nampt in NK cells accelerated the growth of HCC and melanoma. Supplementation of NAD+ precursor, nicotinamide mononucleotide (NMN), significantly improved NK anti‐tumor response in both mouse and human cell‐derived xenograft. Conclusions These findings reveal NAD+ salvage as an essential factor for NK cell homeostasis and function, suggesting a potential strategy for invigorating NK cell‐based immunotherapy.

De novo NAD+ synthesis contributes to CD8+ T cell metabolic fitness and antitumor function

NAD+ supplement potentiates tumor-killing function by rescuing defective TUB-mediated NAMPT transcription in tumor-infiltrated T cells

NAD+ salvage governs mitochondrial metabolism invigorating NK cell anti‐tumor immunity

Reprogramming T-Cell Metabolism for Better Anti-Tumor Immunity

CD38-NAD(+) Axis Regulates Immunotherapeutic Anti-Tumor T Cell Response

Immunosuppression reverse engineered from cancer: Reducing nicotinamide adenine dinucleotide (NAD) impairs effector T cell function through glycolysis

De novo synthesis and salvage pathway coordinately regulate polyamine homeostasis and determine T cell proliferation and function

Metabolic reprogramming of antitumor CD8+ T cells by modulation of GSH-Gpx4 axis

NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion

Targeting metabolic circuitry to supercharge CD8+ T cell antitumor responses

Single-cell NAD(H) levels predict clonal lymphocyte expansion dynamics

T cell metabolic fitness in antitumor immunity

Re-"Formate" T-cell Antitumor Responses

Cancer Cells Tune the Signaling Pathways to Empower de Novo Synthesis of Nucleotides

Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion

Asparagine restriction enhances CD8 + T cell metabolic fitness and antitumoral functionality through an NRF2-dependent stress response

Limiting mitochondrial-derived ATP transfer to the cytosol enhances T-cell activation

NADPH Oxidase 2-Derived Reactive Oxygen Species Promote CD8+ T Cell Effector Function

Targeting NAD metabolism regulates extracellular adenosine levels to improve the cytotoxicity of CD8+ effector T cells in the tumor microenvironment of gastric cancer

Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation

Mitochondrial Biogenesis and Proteome Remodeling Promote One-Carbon Metabolism for T Cell Activation